R&D Partner Content 7th TRP Europe | November 2025, Amsterdam | Agenda Released With new targets like HER2 and FAP coming into focus, and promising data emerging beyond PSMA and SSTR2, real momentum is building in the field.
R&D Partner Content 15th World Clinical Biomarkers & Companion Diagnostics Summi... The biomarkers and diagnostics field continues to boom, driven by advancements in genomic profiling, omics, and AI technologies.
R&D Partner Content 5th iPSC Drug Development Summit Advance iPSC therapies from bench to bedside with 30+ industry experts at this year’s summit.
R&D Partner Content Register Now for AAPS PharmSci 360! Learn from pharmaceutical scientists involved at every stage of the drug development pipeline at PharmSci 360.
R&D Partner Content Injectable Drug Delivery 2025 – Driving Innovation Through C... Press Release: Injectable Drug Delivery 2025 – Driving Innovation Through Collaboration LONDON, UK – 24–25 June 2025
R&D Partner Content 4th In Vivo Cell Engineering & Gene Editing Summit This forum brings together the brightest minds from biopharma, academia, and regulatory leadership to explore the full translational journey
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.